Valion Bio
Valion Bio raised $7.737 million through a private placement of Series B and Series C preferred shares and warrants from investor 3i.
Why it matters for sellers
Fresh capital = new budgets and vendor evaluation window
Signal details
- Financing type
- Series B
- Counterparty
- 3i
- Reported
- September 1, 2026
- Source
- tradingview.com
From the coverage · tradingview.com
737 million. 5 million paid in cash to Valion Bio. The company also agreed to file and maintain a resale registration for the underlying common shares. The deal enhances liquidity while addressing outstanding obligations. Agreement details: Original SEC Filing: Valion Bio, Inc. [ VBIO ] - 8-K - Sep.
Get signals like this for every account you sell to
Our engine detects, verifies, and deduplicates thousands of buying signals every day across 50M+ companies — delivered via API, GCS push, or flat file.
More from the last 24 hours
Salesforce
InvestmentSalesforce led a $166 million funding round in HR platform HiBob, providing the majority of the capital.
CoreWeave
New CustomerPerplexity AI has signed a chip usage agreement with cloud service provider CoreWeave.
Google will pay Entergy Arkansas $526 million to build the Cypress Solar facility, which will power its West Memphis data center.
Yellow Wood Partners
AcquisitionYellow Wood Partners has agreed to acquire the Holistic Health platform, which includes brands like Nature's Bounty, Nuun, Osteo Bi-Flex, and Gard, from Nestlé for $1.0 billion.